Identifying Clinically and Functionally Distinct Groups Among Healthy Controls and First Episode Psychosis Patients by Clustering on EEG Patterns

  title={Identifying Clinically and Functionally Distinct Groups Among Healthy Controls and First Episode Psychosis Patients by Clustering on EEG Patterns},
  author={Xiaodong Qu and Saran Liukasemsarn and Jingxuan Tu and Amy Higgins and T. Hickey and Mei-Hua Hall},
  journal={Frontiers in Psychiatry},
Objective The mismatch negativity (MMN) is considered as a promising biomarker that can inform future therapeutic studies. However, there is a large variability among patients with first episode psychosis (FEP). Also, most studies report a single electrode site and on comparing case–control group differences. Few have taken advantage of the full wealth of multi-channel EEG signals to examine observable patterns. None, to our knowledge, have used machine learning (ML) approaches to investigate… Expand
1 Citations
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review
Multiple EEG-indices were altered during at-risk mental state and early stages of schizophrenia, supporting the hypothesis that cerebral network dysfunctions appear already before the onset of the disorder. Expand


Patterns of deficits in brain function in bipolar disorder and schizophrenia: A cluster analytic study
It is hypothesized that each neurophysiology subgroup may share similar genotypic profiles, which may increase statistical power to detect genetic risk factors in potentially biologically relevant homogenous subgroups independent of diagnostic boundaries. Expand
Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders
Some evidence of the predictive utility of MMN at the early stages of schizophrenia- and affective-spectrum disorders is provided and it is demonstrated that MMN impairments in such patients may worsen over time. Expand
A longitudinal study of event related potentials and correlations with psychosocial functioning and clinical features in first episode psychosis patients.
Examination of multiple ERP components in first episode psychosis (FEP) patients longitudinally and investigated the relationships between ERPs, psychosocial functioning, and clinical features over time highlighted the heterogeneity within the FEP population. Expand
Mismatch negativity is a breakthrough biomarker for understanding and treating psychotic disorders
It is proposed that mismatch negativity (MMN)—a neurophysiological measure of central auditory system functioning—may be informative in developing the next generation of neuroscience-guided cognitive-enhancing treatments. Expand
Disentangling early sensory information processing deficits in schizophrenia
MMN, P3a, and RON are dissociable deficits with distinct relationships to age and medication status in schizophrenia patients, potentially reflecting divergent pathophysiological processes. Expand
Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis
DMMN is a trait marker in the early stages of psychosis, and that small dMMN amplitude in early stagesOf psychosis may reflect altered developmental process rather than progressive brain pathology, and the amplitude of fMMN may not alter in early stage of psychosis. Expand
Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.
These findings further support the importance of MMN reduction in schizophrenia by linking frontotemporal cerebral gray matter pathology to an automatically generated event-related potential index of daily functioning. Expand
Mismatch negativity potentials and cognitive impairment in schizophrenia
In patients, MMN amplitude in frontal electrodes as well as the MMN memory trace effect was diminished compared to controls, which suggests that ERP measures of auditory system adaptability more appropriately characterise the pathophysiological processes underlying cognitive impairment in schizophrenia than static measures of ERP magnitude. Expand
Mismatch Negativity in First-Episode Schizophrenia
A meta-analysis on the fourteen studies that measured MMN to pitch or duration deviants in healthy controls and patients within 12 months of their first episode of schizophrenia indicates that pitch-deviant MMN is not a candidate biomarker for schizophrenia prediction, while duration-devian MMN may hold some promise, albeit nearly a third as large an effect as in chronic schizophrenia. Expand
Auditory steady state response deficits are associated with symptom severity and poor functioning in patients with psychotic disorder
Severity of hallucinatory symptom and community functioning, particularly independent living/meaningful activity, were significantly and independently associated with the 40 Hz ASSR. Expand